Uncommon Therapeuticshttps://uncommontherapeutics.com/

Your landing page’s weakest score is CTA.

How Uncommon Therapeutics ranks

  1. 1.Acadia Pharmaceuticals65
  2. 2.Ultragenyx61
  3. 3.Neurogene52
  4. 4.Taysha Gene Therapies48
  5. 5.Uncommon Therapeutics47
Fix CTA
47Growth scoreupdated

category scores

CTA30Trust42
category scoresShowHide
CTA30Trust42

CTA

30Poor

Copy, size, verb, cost-feel — does the primary CTA earn the click?

Acadia Pharmaceuticals
Ultragenyx
GET TO KNOW OUR STORY
Neurogene

Problems

  • no CTA anywhere above the fold
  • underlined text mimics link, no action
  • only interactive element is video pause
  • mobile fold has zero tappable actions

Trust

42Poor

Proof that the product is real, competent, and safe to try.

Uncommon Therapeutics
Acadia Pharmaceuticals
Trust read
Uncommon Therapeutics"First indication: Rett Syndrome" line naming a specific disease program
Taysha Gene TherapiesNo visible trust signal identified.
NeurogeneNo visible trust signal identified.
Acadia PharmaceuticalsNav links to "Investors," "Pipeline," and "Healthcare Professionals" signaling an established public pharma company
UltragenyxNo visible trust signal identified.

Mobile web

48Poor

The phone experience as a first-class citizen.

Uncommon Therapeutics mobile capture for Mobile web

What works

What to improve

Information hierarchy

58Fair

Does the design help or inhibit what the page is trying to say?

Uncommon Therapeutics desktop capture for Information hierarchy

What works

What to improve

Value props

58Fair

Title, subtitle, hero — do they sell the product's true value?

Uncommon Therapeutics’s headlineUsing the latest technologies to efficiently build drugs that target the underlying cause of rare uncommon diseasesWelcome to the unCommon Era (0 uCE).

Working

Could improve